The Association of Southeast Asian Nations (ASEAN) follows a harmonized framework for pharmaceutical regulatory submissions known as the ASEAN Common Technical Dossier (ACTD). While many global pharma professionals are familiar with ICH-based submissions, the labeling requirements for ASEAN stability data often go underappreciated. This article explores the key components of ASEAN-specific labeling rules that companies must fulfill when filing stability data for drug registration.
📑 ASEAN Regulatory Structure: A Quick Overview
The ACTD framework is used in the following countries: Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Brunei, Cambodia, Laos, and Myanmar. Although the structure of the ACTD is unified, national authorities still retain the right to interpret and enforce labeling rules based on their jurisdictional policies.
- 📌 ACTD Part III: Contains Quality data, including stability data
- 📌 National labeling requirements must align with stability declarations
- 📌 Shelf life, storage conditions, and packaging text must match submitted data
🔑 Labeling Requirements for Outer Packaging
For ASEAN
- 🗹 Product name and strength
- 🗹 Storage conditions (e.g., “Store below 30°C. Protect from moisture.”)
- 🗹 Expiry date as determined from real-time stability data
- 🗹 Batch number, manufacturer details, and regulatory license number
In some ASEAN countries like Malaysia
📄 Inner Labeling and Container Specifications
The primary container (e.g., blister strip, vial label, bottle) must also reflect consistent information with the outer carton. Key requirements include:
- ✅ Short product name and dosage strength
- ✅ Batch number and expiry date
- ✅ Abbreviated storage statement (e.g., “Store below 30°C”)
Omitting or mismatching even a single data point between the stability report and label can trigger product queries from regulatory bodies like EMA or ASEAN NPRA units.
📦 Country-Specific Variations in ASEAN
Though harmonized under ACTD, each ASEAN member may add country-specific labeling requirements. For example:
- 📌 Indonesia (BPOM): Requires inclusion of local registration number and barcode
- 📌 Vietnam (DAV): Emphasizes font size and bilingual instructions
- 📌 Philippines FDA: Mandates the phrase “Food and Drug Administration Registered” on outer packs
Companies filing stability studies across ASEAN must prepare customized artwork packs for each country.
🔖 Storage Conditions: Harmonized Wording Across ASEAN
ASEAN requires that storage conditions mentioned in the stability report align with the label. Stability testing typically follows the ASEAN climatic zone (Zone IVb: 30°C ± 2°C / 75% RH ± 5% RH), and the resulting statements must be reflected in the packaging.
- 💡 Recommended statement: “Store below 30°C. Protect from moisture.”
- 💡 If photostability data is submitted, add: “Protect from light.”
- 💡 Freezing warning (if applicable): “Do not freeze.”
Any deviation from validated storage conditions may require a justification letter or may delay approval.
🔎 Stability Data Alignment with Shelf Life Claims
Stability results must justify the labeled shelf life. The ASEAN guideline expects real-time stability data at long-term conditions (30°C / 75% RH) for the intended shelf life duration. For example, a 24-month shelf life claim must be supported by at least 24 months of real-time data at ASEAN conditions.
- ✅ Ensure packaging used in studies matches final marketed packaging
- ✅ Include justification if extrapolating shelf life beyond available data
- ✅ Highlight microbial stability for oral liquids or sterile injectables
Stability summaries should be detailed in Module 3.2.P.8 of the ACTD and cross-referenced with the labeling content.
📂 Artwork Management and Regulatory Submissions
Proper label artwork must be submitted with the ACTD. Many ASEAN countries require mock-ups during the application stage and final artwork at the end of evaluation.
- 🗄 File formats accepted: PDF or original design files (e.g., .ai or .cdr)
- 🗄 Font size, color contrast, and layout must be clear and legible
- 🗄 For over-the-counter drugs, additional warnings may be required
Inconsistent or missing artwork has been one of the top reasons for delayed product registrations in ASEAN submissions.
📖 Final Thoughts: Get Labeling Right the First Time
ASEAN labeling requirements in stability submissions are non-negotiable. By understanding country-specific expectations, aligning your stability data with proposed label claims, and preparing complete, compliant artwork in advance, you increase your chances of fast-track approvals across the ASEAN region.
Pharma professionals must build cross-functional teams—stability, regulatory, and packaging—to ensure the product label stands scrutiny during ASEAN review.
For deeper insight into stability filing practices globally, also refer to Clinical trial protocol practices that align with regulatory filing.